World Equity Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-2,882
Closed -$251K – 366
2025
Q2
$251K Buy
+2,882
New +$244K 0.07% 275
2024
Q3
– Sell
-8,053
Closed -$634K – 296
2024
Q2
$634K Buy
8,053
+495
+7% +$40.6K 0.19% 139
2024
Q1
$659K Buy
7,558
+475
+7% +$40.5K 0.14% 157
2023
Q4
$559K Buy
7,083
+533
+8% +$40.6K 0.11% 180
2023
Q3
$515K Buy
6,550
+16
+0.2% +$1.34K 0.11% 199
2023
Q2
$576K Sell
6,534
-2,865
-30% -$247K 0.17% 156
2023
Q1
$2.26M Buy
9,399
+3,895
+71% +$317K 0.34% 72
2022
Q4
$428K Buy
5,504
+87
+2% +$7.05K 0.1% 205
2022
Q3
$437K Sell
5,417
-26
-0.5% -$2.34K 0.11% 183
2022
Q2
$489K Sell
5,443
-65
-1% -$6.59K 0.12% 180
2022
Q1
$611K Buy
+5,508
New +$582K 0.13% 183

Other funds holding MDT

World Equity Group's MDT Position: Q3 2025 in Review

World Equity Group sold out of Medtronic (MDT) in Q3 2025, closing a stake of 2,882 shares — an estimated $251K sold.

World Equity Group first reported a position in MDT in Q1 2022 and held it in 11 quarters. The position peaked at $2.26M in Q1 2023. 2,177 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • World Equity Group reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • World Equity Group sold 2,882 Medtronic shares in Q3 2025, an estimated $251K.
  • World Equity Group first reported a position in Medtronic in Q1 2022 and held it in 11 quarters.
  • World Equity Group's Medtronic position peaked at $2.26M in Q1 2023.
  • 2,177 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on World Equity Group's 13F filing for Q3 2025, filed 24 Oct 2025.